Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 275

The DOI matches its Crossref record.

Urokinase Pulmonary Embolism Trial: Phase 1 Results

· 1970 · JAMA

Abstract

In a randomized, national cooperative trial, urokinase and subsequent heparin sodium therapy, when compared to heparin therapy alone, significantly accelerated the resolution rate of pulmonary thromboemboli at 24 hours as shown by pulmonary arteriograms, lung scans, and right-sided pressure measurements. No significant differences in recurrence rate of pulmonary embolism or in the two-week mortality were observed. Bleeding, which occurred in 45% of patients receiving urokinase as contrasted to 27% in the heparin group, was the only complication of urokinase therapy. This increase in bleeding seen with urokinase was closely associated with the invasive procedures necessary to obtain the arteriographic and hemodynamic information. Because the urokinase regimen did not usually achieve complete or nearly complete thrombolysis, and because of its hemorrhagic property, further studies with urokinase in pulmonary thromboembolism are indicated before specific therapeutic recommendations can be made.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.1970.03180120035007

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 275

Metadata

Venue
JAMA
Published
1970-12-21
Volume
214
Issue
12
Pages
2163
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4214640638
Cited by
275
References
0
FWCI
11.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urokinase Pulmonary Embolism Trial: Phase 1 Results. https://app.cochat.ai/papers/10.1001/jama.1970.03180120035007
The paper
Urokinase Pulmonary Embolism Trial: Phase 1 Results. (1970). JAMA. https://doi.org/10.1001/jama.1970.03180120035007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.